226 related articles for article (PubMed ID: 26576960)
1. The associations between proprotein convertase subtilisin/kexin type 9 E670G polymorphism and the risk of coronary artery disease and serum lipid levels: a meta-analysis.
Cai G; Zhang B; Shi G; Weng W; Ma C; Song Y; Zhang J
Lipids Health Dis; 2015 Nov; 14():149. PubMed ID: 26576960
[TBL] [Abstract][Full Text] [Related]
2. Proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism interacts with alcohol consumption to modulate serum lipid levels.
Aung LH; Yin RX; Wu DF; Cao XL; Hu XJ; Miao L
Int J Med Sci; 2013; 10(2):124-32. PubMed ID: 23329883
[TBL] [Abstract][Full Text] [Related]
3. The proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations.
Aung LH; Yin RX; Miao L; Hu XJ; Yan TT; Cao XL; Wu DF; Li Q; Pan SL; Wu JZ
Lipids Health Dis; 2011 Jan; 10():5. PubMed ID: 21232153
[TBL] [Abstract][Full Text] [Related]
4. The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan.
Hsu LA; Teng MS; Ko YL; Chang CJ; Wu S; Wang CL; Hu CF
Clin Chem Lab Med; 2009; 47(2):154-8. PubMed ID: 19191720
[TBL] [Abstract][Full Text] [Related]
5. Effect of E670G Polymorphism in PCSK9 Gene on the Risk and Severity of Coronary Heart Disease and Ischemic Stroke in a Tunisian Cohort.
Slimani A; Harira Y; Trabelsi I; Jomaa W; Maatouk F; Hamda KB; Slimane MN
J Mol Neurosci; 2014 Jun; 53(2):150-7. PubMed ID: 24599757
[TBL] [Abstract][Full Text] [Related]
6. Combined PCSK9 and APOE polymorphisms are genetic risk factors associated with elevated plasma lipid levels in a Thai population.
Jeenduang N; Porntadavity S; Wanmasae S
Lipids; 2015 Jun; 50(6):543-53. PubMed ID: 25899039
[TBL] [Abstract][Full Text] [Related]
7.
Mohamed SH; Hassaan MMM; Ibrahim BA; Sabbah NA
Genet Test Mol Biomarkers; 2021 Sep; 25(9):615-623. PubMed ID: 34550777
[No Abstract] [Full Text] [Related]
8. Serum PCSK9 levels, but not PCSK9 polymorphisms, are associated with CAD risk and lipid profiles in southern Chinese Han population.
Cai G; Yu L; Huang Z; Li L; Fu X
Lipids Health Dis; 2018 Sep; 17(1):213. PubMed ID: 30205809
[TBL] [Abstract][Full Text] [Related]
9. A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis.
Chen SN; Ballantyne CM; Gotto AM; Tan Y; Willerson JT; Marian AJ
J Am Coll Cardiol; 2005 May; 45(10):1611-9. PubMed ID: 15893176
[TBL] [Abstract][Full Text] [Related]
10. ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9.
Li S; Xu RX; Guo YL; Zhang Y; Zhu CG; Sun J; Li JJ
Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):411-7. PubMed ID: 25466598
[TBL] [Abstract][Full Text] [Related]
11.
Li YY; Wang H; Yang XX; Geng HY; Gong G; Lu XZ
Front Cardiovasc Med; 2020; 7():582865. PubMed ID: 33244470
[No Abstract] [Full Text] [Related]
12. [Influence of PCSK9 gene E670G polymorphism on the risk of atherosclerotic coronary heart disease and plasma lipid level].
Zhang N; Gao J; Liu Y; Sun G
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Oct; 34(5):749-754. PubMed ID: 28981947
[TBL] [Abstract][Full Text] [Related]
13. What is the impact of PCSK9 rs505151 and rs11591147 polymorphisms on serum lipids level and cardiovascular risk: a meta-analysis.
Qiu C; Zeng P; Li X; Zhang Z; Pan B; Peng ZYF; Li Y; Ma Y; Leng Y; Chen R
Lipids Health Dis; 2017 Jun; 16(1):111. PubMed ID: 28606094
[TBL] [Abstract][Full Text] [Related]
14. The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men.
Scartezini M; Hubbart C; Whittall RA; Cooper JA; Neil AH; Humphries SE
Clin Sci (Lond); 2007 Dec; 113(11):435-41. PubMed ID: 17550346
[TBL] [Abstract][Full Text] [Related]
15. Risk prediction with proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with stable coronary disease on statin treatment.
Werner C; Hoffmann MM; Winkler K; Böhm M; Laufs U
Vascul Pharmacol; 2014 Aug; 62(2):94-102. PubMed ID: 24685817
[TBL] [Abstract][Full Text] [Related]
16.
Lin Z; Wang SH; Wei DY; Wang LM; Zhang ZW
J Int Med Res; 2019 Dec; ():300060519892177. PubMed ID: 31840538
[TBL] [Abstract][Full Text] [Related]
17. E670G polymorphism of PCSK9 gene of patients with coronary heart disease among Han population in Hainan and three provinces in the northeast of China.
He XM; Chen L; Wang TS; Zhang YB; Luo JB; Feng XX
Asian Pac J Trop Med; 2016 Feb; 9(2):172-6. PubMed ID: 26919950
[TBL] [Abstract][Full Text] [Related]
18. Association of plasma small dense LDL cholesterol with PCSK9 levels in patients with angiographically proven coronary artery disease.
Zhang Y; Xu RX; Li S; Zhu CG; Guo YL; Sun J; Li JJ
Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):426-33. PubMed ID: 25770756
[TBL] [Abstract][Full Text] [Related]
19. Proprotein convertase subtilisin-kexin type 9 as a biomarker for the severity of coronary artery disease.
Li S; Zhang Y; Xu RX; Guo YL; Zhu CG; Wu NQ; Qing P; Liu G; Dong Q; Li JJ
Ann Med; 2015; 47(5):386-93. PubMed ID: 26153823
[TBL] [Abstract][Full Text] [Related]
20. Influence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjects.
Anderson JM; Cerda A; Hirata MH; Rodrigues AC; Dorea EL; Bernik MM; Bertolami MC; Faludi AA; Hirata RD
J Clin Lipidol; 2014; 8(3):256-64. PubMed ID: 24793346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
